000 01330 a2200409 4500
005 20250512112258.0
264 0 _c19740405
008 197404s 0 0 eng d
022 _a0067-7957
024 7 _a10.1159/000427821
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGerhartz, H
245 0 0 _aCombined chemotherapy of acute myeloblastic leukemia.
_h[electronic resource]
260 _bBibliotheca haematologica
_c1973
300 _a1142-6 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAdult
650 0 4 _aAge Factors
650 0 4 _aAsparaginase
_xtherapeutic use
650 0 4 _aChild
650 0 4 _aCytarabine
_xtherapeutic use
650 0 4 _aDaunorubicin
_xtherapeutic use
650 0 4 _aDoxorubicin
_xtherapeutic use
650 0 4 _aDrug Synergism
650 0 4 _aDrug Therapy, Combination
650 0 4 _aHumans
650 0 4 _aLeukemia, Myeloid, Acute
_xdrug therapy
650 0 4 _aPrednisone
_xtherapeutic use
650 0 4 _aRemission, Spontaneous
650 0 4 _aVincristine
_xtherapeutic use
700 1 _aBleihöfer, B
700 1 _aEnglebert, B
700 1 _aPaulisch, R
700 1 _aSchneider, J
773 0 _tBibliotheca haematologica
_gvol. 39
_gp. 1142-6
856 4 0 _uhttps://doi.org/10.1159/000427821
_zAvailable from publisher's website
999 _c4525816
_d4525816